Health policy

Citations 91-100 of 129 total displayed.

Congenital heart disease
Health related quality of life and health status in adult survivors with previously operated complex congenital heart disease

M Kamphuis, J Ottenkamp, H W Vliegen, T Vogels, K H Zwinderman, R P Kamphuis, and S P Verloove-Vanhorick
Heart 2002; 87: 356-362. [Abstract] [Full text] [PDF] [Request Permissions]  

Editorials
Intracoronary stenting: developments since the NICE report

A H Gershlick
Heart 2002; 87: 187-190. [Extract] [Full text] [PDF] [Request Permissions]  

Scientific letters
Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic?

A Mosterd, J B Reitsma, and D E Grobbee
Heart 2002; 87: 75-76. [Extract] [Full text] [PDF] [Request Permissions]  

Editorials
Consent in cardiac practice

ARVINDER S KURBAAN, SALLY SMITH, and PETER G MILLS
Heart 2001; 86: 593-594. [Extract] [Full text] [PDF] [Request Permissions]  

Scientific letters
Sedation by physician with diazepam for DC cardioversion of atrial arrhythmias

P J PUGH, P SPURRELL, K KAMALVAND, and A N SULKE
Heart 2001; 86: 572-573. [Extract] [Full text] [Request Permissions]  

Cardiovascular medicine
Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey

I U Haq, L E Ramsay, E J Wallis, C G Isles, L D Ritchie, and P R Jackson
Heart 2001; 86: 289-295. [Abstract] [Full text] [PDF] [Request Permissions]  

Interventional cardiology and surgery
Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial

F McHugh, G M Lindsay, P Hanlon, I Hutton, M R Brown, C Morrison, and D J Wheatley
Heart 2001; 86: 317-323. [Abstract] [Full text] [PDF] [Request Permissions]  

Education in Heart
ELECTROPHYSIOLOGY: Implantable cardioverter-defibrillators

Derek T Connelly
Heart 2001; 86: 221-226. [Extract] [Full text] [PDF] [Request Permissions]  

Editorials
National Institute for Clinical Excellence guidance: too NICE to glycoprotein IIb/IIIa inhibitors?

CHARLES J KNIGHT
Heart 2001; 85: 481-483. [Extract] [Full text] [PDF] [Request Permissions]  

Cardiovascular medicine
Cost effectiveness of ramipril treatment for cardiovascular risk reduction

I S Malik, V K Bhatia, and J S Kooner
Heart 2001; 85: 539-543. [Abstract] [Full text] [PDF] [Request Permissions]